Recently, Neuroscientists from the Indiana University (IU) Gill Center for Biomolecular Science received more than $2 million from the NIH's National Institute on Drug Abuse (NIDA) to study the impact of cannabis use during adolescence. Using mice, their goal is to develop therapies to treat adverse cannabis effects in humans.
"This is a significant public health concern. Today's cannabis strains are being bred for increased THC content. It's very different and much riskier than the more traditional strains used in the past. There's an urgent need to understand the effects of these new strains," said Hui-Chen Lu, director of the Gill Center and professor in the IU College of Arts and Sciences' Department of Psychological and Brain Sciences.
